Consistent with this, we showed that copy number amplification drives MRPL47 overexpression in lung cancer, with amplified samples exhibiting significantly elevated MRPL47 expression compared to normal and diploid samples (p-value< 0.0001) (Fig. 1E). Here, MRPL47 is linked to lung carcinoma.